HomeWXIBF • OTCMKTS
add
WuXi Biologics (Cayman) Inc
Previous close
$2.25
Day range
$1.86 - $1.86
Year range
$1.30 - $6.60
Market cap
62.41B HKD
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.29B | 0.97% |
Operating expense | 765.14M | 21.62% |
Net income | 749.54M | -33.86% |
Net profit margin | 17.48 | -34.51% |
Earnings per share | — | — |
EBITDA | 1.24B | -13.32% |
Effective tax rate | 11.36% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.53B | 9.60% |
Total assets | 56.11B | 7.60% |
Total liabilities | 11.46B | -12.46% |
Total equity | 44.64B | — |
Shares outstanding | 4.15B | — |
Price to book | 0.23 | — |
Return on assets | 4.05% | — |
Return on capital | 4.62% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 749.54M | -33.86% |
Cash from operations | 651.06M | -52.65% |
Cash from investing | -191.26M | 75.93% |
Cash from financing | -737.79M | -684.70% |
Net change in cash | -258.16M | -153.79% |
Free cash flow | 350.65M | 52.56% |
About
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Founded
2010
Website
Employees
12,435
